High-Dose Acetaminophen with Concurrent CYP2E1 Inhibition Has Profound Anticancer Activity without Liver Toxicity
The Journal of Pharmacology and Experimental Therapeutics · 2024-01 · 388 (1) · 209-217
DOI: 10.1124/jpet.123.001772 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024-01. Verfasst von Allyn Bryan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterans Affairs, Richmond, Virginia. (A.B., P.P., W.S.L., B.P., A.N.); Departments of Oral and Craniofacial Molecular Biology (A.F.) a…. Hauptthemen laut MEDLINE: Acetaminophen, Cytochrome P-450 CYP2E1. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Acetaminophen (AAP) is metabolized by a variety of pathways such as sulfation, glucuronidation, and fatty acid amide hydrolase-mediated conversion to the active analgesic metabolite AM404. CYP2E1-mediated metabolism to the hepatotoxic reactive metabolite NAPQI (N-acetyl-p-benzoquinone imine) is a minor metabolic pathway that has not been linked to AAP therapeutic benefits yet clearly leads to AAP liver toxicity. N-acetylcysteine (NAC) (an antioxidant) and fomepizole (a CYP2E1 inhibitor) are clinically used for the treatment of AAP toxicity. Mice treated with AAP in combination with fomepizole (plus or minus NAC) were assessed for liver toxicity by histology and serum chemistry. The anticancer activity of AAP with NAC and fomepizole rescue was assessed in vitro and in vivo. Fomepizole with or without NAC completely prevented AAP-induced liver toxicity. In vivo, high-dose AAP with NAC/fomepizole rescue had profound antitumor activity against commonly used 4T1 breast tumor and lewis lung carcinoma lung tumor models, and no liver toxicity was detected. The antitumor efficacy was reduced in immune-compromised NOD-scid IL2Rgammanull mice, suggesting an immune-mediated mechanism of action. In conclusion, using fomepizole-based rescue, we were able to treat mice with 100-fold higher than standard dosing of AAP (650 mg/kg) without any detected liver toxicity and substantial antitumor activity. SIGNIFICANCE STATEMENT: High-dose acetaminophen can be given concurrently with CYP2E1 inhibition to allow for safe dose escalation to levels needed for anticancer activity without detected evidence of toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Veterans Affairs, Richmond, Virginia. (A.B., P.P., W.S.L., B.P., A.N.); Departments of Oral and Craniofacial Molecular Biology (A.F.) and Human and Molecular Genetics (J.L., L.M.), Virginia Commonwealth Un…
ORCID-Profile: Hartmut Jaeschke
Förderung
- NCATS NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- BLRD VA
- NIA NIH HHS
Zitieren
APA
Bryan, A., Pingali, P., Faber, A., Landry, J., Akakpo, J. Y., Jaeschke, H., Li, H., Lee, W. S., May, L., Patel, B., & Neuwelt, A. (2024). High-Dose Acetaminophen with Concurrent CYP2E1 Inhibition Has Profound Anticancer Activity without Liver Toxicity. The Journal of Pharmacology and Experimental Therapeutics, 388(1), 209-217. https://doi.org/10.1124/jpet.123.001772
Vancouver
Bryan A, Pingali P, Faber A, Landry J, Akakpo JY, Jaeschke H, et al. High-Dose Acetaminophen with Concurrent CYP2E1 Inhibition Has Profound Anticancer Activity without Liver Toxicity. The Journal of Pharmacology and Experimental Therapeutics. 2024;388(1):209-217. doi:10.1124/jpet.123.001772
BibTeX
@article{Bryan2024,
author = {Bryan, Allyn and Pingali, Pavani and Faber, Anthony and Landry, Joseph and Akakpo, Jephte Y and Jaeschke, Hartmut and Li, Howard and Lee, Won Sok and May, Lauren and Patel, Bhaumik and Neuwelt, Alex},
title = {High-Dose Acetaminophen with Concurrent CYP2E1 Inhibition Has Profound Anticancer Activity without Liver Toxicity},
journal = {The Journal of Pharmacology and Experimental Therapeutics},
year = {2024},
volume = {388},
number = {1},
pages = {209--217},
doi = {10.1124/jpet.123.001772}
}
EUVIMED